Walker Neal bought ACRS
February 3, 2026 · Form 4 insider transaction
Walker Neal bought 63,475 shares of Aclaris Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
63,475
Price
N/A
Total value
N/A
InsiderWalker Neal
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 3, 2026
Filing dateFebruary 5, 2026
Shares owned after1,562,497
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.